Nuveen Asset Management’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $150K | Sell |
|
|||||
|
2023
Q4 | $536K | Buy |
|
|||||
|
2023
Q3 | $667K | Sell |
|
|||||
|
2023
Q2 | $2.02M | Buy |
|
|||||
|
2023
Q1 | $3.14M | Buy |
|
|||||
|
2022
Q4 | $3.8M | Buy |
|
|||||
|
2022
Q3 | $9.66M | Buy |
|
|||||
|
2022
Q2 | $6.86M | Buy |
|
|||||
|
2022
Q1 | $3.75M | Sell |
|
|||||
|
2021
Q4 | $4.53M | Buy |
|
|||||
|
2021
Q3 | $4.05M | Buy |
|
|||||
|
2021
Q2 | $2.45M | Sell |
|
|||||
|
2021
Q1 | $5.02M | Buy |
|
|||||
|
2020
Q4 | $3.03M | Buy |
|
|||||
|
2020
Q3 | $1.49M | Sell |
|
|||||
|
2020
Q2 | $2.21M | Sell |
|
|||||
|
2020
Q1 | $1.41M | Sell |
|
|||||
|
2019
Q4 | $4.11M | Buy |
|
|||||
|
2019
Q3 | $330K | Buy |
|
|||||
|
2019
Q2 | $147K | Buy |
|